Qlaris Bio has reported positive topline outcomes from two randomised Phase II US trials, Osprey and Apteryx, of QLS 111 in individuals with primary open-angle glaucoma (POAG) and ocular hypertension ...
AMSTERDAM, Feb. 27, 2026 /PRNewswire/ -- As e-commerce volumes continue to grow, GOFO, a fast-growing global last-mile delivery provider active in the Netherlands, has entered into a strategic ...
DEDHAM, Mass.--(BUSINESS WIRE)--Qlaris Bio, Inc., a clinical‐stage biotechnology company dedicated to developing first‐in‐class therapies for glaucoma, today announced that new data from studies of ...
DEDHAM, Mass.--(BUSINESS WIRE)--Qlaris Bio, Inc. (“Qlaris”), a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced the initiation and dosing ...
RoadOne IntermodaLogistics' affiliate, QLS Logistic Services LLC, has acquired US Intermodal, Inc., an intermodal trucking and drayage business, which will function as the core of a new, ...
QLS Holdings (7075) has delivered a -7.83% change over the past year, with a 52-week range between 536.00 and 893.00. What Is the Average Daily Trading Volume of QLS Holdings (7075)? The average daily ...
Determining whether QLS Holdings Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current QLS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results